GSK plc publishes stock exchange announcements
GSK plc regularly issues regulatory announcements to the London and New York stock exchanges, covering financial results and director changes. The company provides direct access to these official disclosures for stakeholders.
GSK plc maintains a section on its website dedicated to regulatory announcements submitted to the London Stock Exchange (RNS) and the U.S. Securities and Exchange Commission (SEC) for filings with the New York Stock Exchange.
These announcements encompass key corporate information, including quarterly and annual financial results, dividend information, and changes within the company's directorate. GSK offers investors and other stakeholders direct access to these official disclosures, ensuring transparency in its stock exchange activities.
The company also distributes specific announcements related to "inside information" to the London Stock Exchange. Additionally, the website aggregates links to press releases, quarterly results, and information tailored for shareholders, such as dividend details and share management tools.
GSK's website also provides a subscription service for stock exchange announcements delivered via email. The company utilizes website cookies to enhance user experience and deliver relevant content and advertising.